Concordant expression of the telomerase-associated genes in non-small cell lung cancer

European Journal of Surgical Oncology

Volumn 29, Issue 7, 2003, Pages 594-599

  Hsu, Chung Ping ^a,b   Miaw, J ^a   Hsia, J Y ^a   Shai, S E ^a   Chen, C Y ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

c Mcy; h TERT; Lung cancer; Telomerase; TFR1; TRF2

Indexed keywords

BINDING PROTEIN; HOLOENZYME; MYC PROTEIN; TELOMERASE; TELOMERASE ASSOCIATED PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERIC REPEAT BINDING FACTOR 2; TRANSCRIPTASE; TTAGGG REPEAT BINDING FACTOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

EID: 0141569761     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00108-2     Document Type: Article

References (31)

1. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu JR. A highly conserved repetitive DNA sequence (TTAGGG)n present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6622-6.
2. Cross SH, Allshire RC, McKay SJ, McGill NI, Cooke HJ. Cloning of human telomeres by complementation in years. Nature 1989; 338: 774-6.
3. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-73.
4. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 1997; 276: 561-7.
5. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J. The RNA component of human telomerase. Science 1995; 269: 1236-41.
6. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO. A mammalian telomerase-associated protein. Science 1997; 275: 973-7.
7. Liu Y, Snow BE, Hande MP, Baerlocher G, Kickhoefer VA, Yeung D, Wakeham A, Itie A, Siderovski DP, Lansdorp PM, Robinson MO, Harrington L. Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo. Biol 2000; 20: 8178-84.
8. Harley CB. Telomere loss: Mitotic clock or genetic time bomb? Mutat Res 1991; 256: 271-81.
9. Hiyama K, Hirai Y, Kyoizumi S, Akiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-5.
10. Chiu CP, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, Harley CB, Lansdorp PM. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996; 14: 239-48.
11. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of lifespan by introduction of telomerase into normal human cells. Science 1998; 279: 349-52.
12. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu CP. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 1999; 21: 111-4.
13. Xu D, Popov N, Hou M, Wang Q, Bjorkholm M, Gruber A, Menkel AR, Henriksson M. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci 2001; 98: 3826-31.
14. van Steensel B, de Lange T. Control of telomere length by the human delomeric protein TRF1. Nature 1997; 385: 740-73.
15. van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998; 92: 401-13.
16. Smith S, Giriat I, Schmitt A, de Lange T. Tankyrase, a poly (ADP-ribose) polymerase at human telomeres. Science 1998; 282: 1484-7.
17. In: Fleming ID, Cooper JS, Henson DE, et al. (eds) AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott, 1997: 65-9.
18. Nakano K, Watney E, McDougall JK. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am J Pathol 1998; 153: 857-64.
19. Takagi S, Kinouchi Y, Hiwatashi N, Chida M, Nagashima F, Takahashi S, Negoro K, Shimosegawa T, Toyota T. Telomerase shortening and the clinicopathologic characteristics of human colorectal carcinomas. Cancer 1999; 86: 1431-6.
20. Zhang DK, Ngan HYS, Cheng RYS, Cheung ANY, Liu SS, Tsao SW. Clinical significance of telomerase activity and telomeric restriction fragment (TRF) in cervical cancer. Eur J Cancer 1999; 35: 154-60.
21. Chang LY, Lin SC, Chang CS, Wong YK, Hu YC, Chang KW. Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis. J Oral Pathol Med 1999; 28: 389-96.
22. Marchetti A, Bertacca G, Buttitta F, Chella A, Quattrocolo G, Angeletti CA, Bevilacqua G. Telomerase activity as a prognostic indicator in stage 1 non-small cell lung cancer. Clin Cancer Res 1999; 5: 2077-81.
23. Wu X, Kemp B, Amos CI, Honn SE, Zhang W, Walsh GL, Spitz MR. Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer. Brit J Cancer 1999; 80: 453-7.
24. Taga S, Osaki T, Ohgami A, Imoto H, Yasumoto K. Prognostic impact of telomerase activity in non-small cell lung cancers. Ann Surg 1999; 230: 715-20.
25. Kyo S, Takahura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acid Res 2000; 28: 669-77.
26. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M. Cloning of human telomerase catalytic subunits (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activity in immortalized and cancer cells. Cancer Res 1999; 59: 551-7.
27. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002; 295: 2446-9.
28. Sagawa S, Nishi H, Isaka K, Fujito A, Takayama M. The correlation of TERT expression with c-myc expression in cervical cancer. Cancer Lett 2001; 168: 4-50.
29. Kameshima H, Yagihashi A, Yajima T, Kobayashi D, Hirata K, Watanabe N. Expression of telomerase-associated genes: reflection of telomerase activity in gastric cancer? World J Surg 2001; 25: 285-9.
30. Shibuya K, Fujisawa T, Hoshino H, Baba M, Saitoh Y, Iizasa T, Sekine Y, Hiroshima K, Ohwada H. Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung. Cancer 2001; 92: 849-55.
31. Gertier R, Rosenberg R, Stricker D, Werner M, Lassmann S, Ulm K, Nekarda H, Siewert JR. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma. Cancer 2002; 95: 2103-11.